Therapeutic benefits of a component of coffee in a rat model of Alzheimer's disease

Gustavo Basurto-Islas, Julie Blanchard, Yunn Chyn Tung, Jose R. Fernandez, Michael Voronkov, Maxwell Stock, Sherry Zhang, Jeffry B. Stock, Khalid Iqbal

Research output: Contribution to journalArticle

28 Scopus citations

Abstract

A minor component of coffee unrelated to caffeine, eicosanoyl-5-hydroxytryptamide (EHT), provides protection in a rat model for Alzheimer's disease (AD). In this model, viral expression of the phosphoprotein phosphatase 2A (PP2A) endogenous inhibitor, the I2PP2A, or SET protein in the brains of rats leads to several characteristic features of AD including cognitive impairment, tau hyperphosphorylation, and elevated levels of cytoplasmic amyloid-β protein. Dietary supplementation with EHT for 6-12 months resulted in substantial amelioration of all these defects. The beneficial effects of EHT could be associated with its ability to increase PP2A activity by inhibiting the demethylation of its catalytic subunit PP2Ac. These findings raise the possibility that EHT may make a substantial contribution to the apparent neuroprotective benefits associated with coffee consumption as evidenced by numerous epidemiologic studies indicating that coffee drinkers have substantially lowered risk of developing AD.

Original languageEnglish (US)
Pages (from-to)2701-2712
Number of pages12
JournalNeurobiology of Aging
Volume35
Issue number12
DOIs
StatePublished - Dec 1 2014

All Science Journal Classification (ASJC) codes

  • Neuroscience(all)
  • Aging
  • Clinical Neurology
  • Developmental Biology
  • Geriatrics and Gerontology

Keywords

  • Adenoassociated virus vector serotype 1
  • Coffee
  • Cognitive impairment
  • Eicosanoyl-5-hydroxytryptamide
  • Hyperphosphorylation of tau
  • Inhibitor-2 of protein phosphatase-2A
  • Methylation of protein phosphatase-2A
  • Protein phosphatase-2A
  • Rat model of sporadic Alzheimer's disease
  • SET
  • Tau

Fingerprint Dive into the research topics of 'Therapeutic benefits of a component of coffee in a rat model of Alzheimer's disease'. Together they form a unique fingerprint.

  • Cite this

    Basurto-Islas, G., Blanchard, J., Tung, Y. C., Fernandez, J. R., Voronkov, M., Stock, M., Zhang, S., Stock, J. B., & Iqbal, K. (2014). Therapeutic benefits of a component of coffee in a rat model of Alzheimer's disease. Neurobiology of Aging, 35(12), 2701-2712. https://doi.org/10.1016/j.neurobiolaging.2014.06.012